Sarepta Stock Plunges After Gene Therapy Safety Concerns

Sarepta’s stock crashed 25% after a third patient death linked to its gene therapy. What does this mean for the...

18/07/2025

1 views

FDA’s COVID Vaccine Stance: Safety Concerns Rise

FDA faces heat over COVID vaccine approvals. Are safety concerns being ignored? Dive into the debate and what it means...

17/07/2025

2 views

A new Chinese obesity drug shows stunning results, rivaling Zepbound. Could this reshape the weight loss market? Click to find...

16/07/2025

2 views

Why is COVID-19 vaccine reform moving so slowly? Dive into the clash between science, industry, and public trust. What’s really...

06/06/2025

0 views